STENTiT

STENTiT develops the Resorbable Fibrillated Scaffold (RFS), a temporary vascular support structure designed to reconstruct arteries from the inside-out. The device provides immediate blood flow restoration and facilitates a natural healing response before being resorbed by the body. The company's primary focus is treating patients with below-the-knee chronic limb-threatening ischemia (CLTI) to prevent amputations caused by severe blood flow restriction.